How did AFLAC's key business segments perform in the third quarter of 2003?

Both AFLAC Japan and AFLAC U.S. showed strong performance. AFLAC Japan's pretax operating earnings increased by 14.1% to $276 million, supported by robust premium growth and favorable benefit ratios, driven by strong sales of its EVER medical policy. AFLAC U.S. saw a 16.5% increase in pretax operating earnings to $117 million, although management noted efforts to improve distribution and sales growth in this segment.

What was the impact of foreign currency fluctuations on AFLAC's results?

The strengthening yen against the dollar had a mixed impact. For reporting purposes, a stronger yen increased reported dollar-denominated assets and liabilities. Operationally, AFLAC aims to manage currency risk by matching yen-denominated assets and liabilities. The company's primary financial objective is the growth of operating earnings per diluted share, excluding currency fluctuations, and management provided targets based on this exclusion. For the nine months, foreign currency translation increased operating earnings by approximately $0.04 per diluted share.

What is AFLAC's investment strategy and how is the portfolio performing?

AFLAC's investment philosophy emphasizes maximizing income while prioritizing liquidity, safety, and quality. The company invests primarily in investment-grade debt securities. At September 30, 2003, total investments and cash amounted to $42.7 billion. The overall credit quality of the portfolio remains high, and the company actively manages its investment portfolio to match asset and liability durations, although it noted potential interest rate sensitivity.

What are the key initiatives or challenges mentioned for AFLAC U.S.?

While AFLAC U.S. experienced an increase in pretax operating earnings, management expressed disappointment with overall sales growth in 2003. To address this, the company is focusing on enhancing its distribution system by expanding the field management network and increasing sales coordinators. They are also introducing new versions of key insurance policies, such as accident, cancer, and short-term disability, believing these long-term strategies will benefit future sales growth.

AFL 10-Q Quarterly Report Q3 FY2003 — Revenue, Net Income, EPS

Summary

AFLAC INCORPORATED reported solid financial results for the third quarter and first nine months of 2003, demonstrating continued revenue growth and profitability. Total revenues increased to $2.93 billion for the quarter and $8.60 billion for the nine months. Net earnings were $237 million for the quarter and $723 million for the nine months. The company's primary segments, AFLAC Japan and AFLAC U.S., both showed significant increases in pretax operating earnings, driven by strong premium growth and effective expense management. AFLAC Japan, the larger segment, experienced robust premium income growth, benefiting from strong sales of its new medical policy, EVER, and a favorable benefit ratio. AFLAC U.S. also saw premium growth, though management noted disappointment with overall sales performance and outlined initiatives to enhance its distribution system. The company's investment portfolio remains high-quality, with a focus on preserving capital while generating income. Management is optimistic about future growth, raising its operating earnings per diluted share growth target for 2003.

Key Highlights

1Total revenues increased by 8.3% to $2.93 billion for the third quarter and 13.3% to $8.60 billion for the nine months ended September 30, 2003.
2Net earnings were $237 million for the quarter and $723 million for the nine months, representing year-over-year increases of 13.9% for the nine-month period.
3AFLAC Japan's pretax operating earnings grew by 14.1% to $276 million for the quarter and 21.0% to $843 million for the nine months.
4AFLAC U.S.'s pretax operating earnings increased by 16.5% to $117 million for the quarter and 12.7% to $327 million for the nine months.
5Total new annualized premium sales in Japan increased by 17.5% to $251 million for the quarter, driven by the EVER medical policy.
6The company raised its 2003 objective for operating earnings per diluted share growth, excluding currency impact, to 17%, targeting $1.83.
7Investments and cash totaled $42.7 billion, with a focus on maintaining a high-quality, investment-grade portfolio.

AFLAC INC Quarterly Report for Q3 Ended Sep 30, 2003

Summary

Key Highlights

Frequently Asked Questions